Science Explorer Back to mapMap
Discussion
Company · Jena · Germany

Biolitec (Germany)

Research works
36
▼ 47% vs 2018-21
Citations
1.4k
40.0 per fractional work
Top-10% rate
8.6%
all institutions 10.0%
Open access
31%
world 40%
International
50%
world 18%

Not ranked overall: Biolitec (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Biolitec (Germany) work in?

In all years, 39% of research at Biolitec (Germany) is in Health Sciences, 36% in Physical Sciences. Its largest fields are Medicine (37%), Engineering (20%), Biochemistry, Genetics and Molecular Biology (14%). It does 1.5× the world's share of Health Sciences.

Health Sciences: 14 fractional works · 39.3% of its workMedicine: 13 fractional works · 36.5% of its workPulmonary and Respiratory Medicine: 8 fractional works · 23.4% of its workDermatology: 2 fractional works · 5.3% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 4.1% of its workEpidemiology: 0 fractional works · 1.1% of its workOphthalmology: 0 fractional works · 0.8% of its workRheumatology: 0 fractional works · 0.7% of its workOncology: 0 fractional works · 0.3% of its workRehabilitation: 0 fractional works · 0.3% of its workHematology: 0 fractional works · 0.2% of its workInfectious Diseases: 0 fractional works · 0.2% of its workDentistry: 1 fractional works · 2.3% of its workPeriodontics: 1 fractional works · 1.6% of its workOral Surgery: 0 fractional works · 0.7% of its workVeterinary: 0 fractional works · 0.3% of its workSmall Animals: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 0.1% of its workPhysical Sciences: 13 fractional works · 36.2% of its workEngineering: 7 fractional works · 19.7% of its workBiomedical Engineering: 6 fractional works · 17.6% of its workElectrical and Electronic Engineering: 1 fractional works · 2.1% of its workMaterials Science: 4 fractional works · 11.2% of its workMaterials Chemistry: 3 fractional works · 7.9% of its workBiomaterials: 1 fractional works · 2.7% of its workPolymers and Plastics: 0 fractional works · 0.2% of its workSurfaces, Coatings and Films: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 1 fractional works · 3.1% of its workOrganic Chemistry: 0 fractional works · 1.2% of its workInorganic Chemistry: 0 fractional works · 0.8% of its workAnalytical Chemistry: 0 fractional works · 0.5% of its workSpectroscopy: 0 fractional works · 0.4% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.2% of its workEnvironmental Science: 1 fractional works · 1.6% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.7% of its workEcology: 0 fractional works · 0.5% of its workEnvironmental Chemistry: 0 fractional works · 0.5% of its workPhysics and Astronomy: 0 fractional works · 0.4% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemical Engineering: 0 fractional works · 0.2% of its workBioengineering: 0 fractional works · 0.2% of its workLife Sciences: 8 fractional works · 23.1% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 13.8% of its workMolecular Biology: 3 fractional works · 9.6% of its workBiophysics: 1 fractional works · 1.5% of its workCancer Research: 1 fractional works · 1.5% of its workBiotechnology: 0 fractional works · 0.9% of its workCell Biology: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 4.7% of its workPharmaceutical Science: 2 fractional works · 4.7% of its workAgricultural and Biological Sciences: 1 fractional works · 2.9% of its workInsect Science: 1 fractional works · 1.6% of its workFood Science: 0 fractional works · 1.4% of its workImmunology and Microbiology: 1 fractional works · 1.6% of its workImmunology: 0 fractional works · 1.2% of its workMicrobiology: 0 fractional works · 0.5% of its workSocial Sciences: 0 fractional works · 1.4% of its workSocial Sciences: 0 fractional works · 0.7% of its workHealth: 0 fractional works · 0.7% of its workBusiness, Management and Accounting: 0 fractional works · 0.5% of its workMarketing: 0 fractional works · 0.2% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workDecision Sciences: 0 fractional works · 0.2% of its workInformation Systems and Management: 0 fractional works · 0.2% of its workALL ITS WORKBiolitec(Germany)36fractional works, all years
Life Sciences23%Physical Sciences36%Health Sciences39%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Medicine1336.5%
    2. Dentistry12.3%
    3. Veterinary00.3%
    4. Health Professions00.1%
    1. Engineering719.7%
    2. Materials Science411.2%
    3. Chemistry13.1%
    4. Environmental Science11.6%
    5. Physics and Astronomy00.4%
    6. Chemical Engineering00.2%
    1. Biochemistry, Genetics and Molecular Biology513.8%
    2. Pharmacology, Toxicology and Pharmaceutics24.7%
    3. Agricultural and Biological Sciences12.9%
    4. Immunology and Microbiology11.6%
    1. Social Sciences00.7%
    2. Business, Management and Accounting00.5%
    3. Decision Sciences00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Biolitec (Germany)?

Ranked on the quality score, Dietrich Scheglmann, Burkhard Gitter and Volker Albrecht lead among researchers whose main affiliation is Biolitec (Germany).

  1. 1 Dietrich Scheglmann Germany · #1,325,234 worldwide 1.7k citations · 26 works
  2. 2 Burkhard Gitter Germany · #1,659,863 worldwide 1.1k citations · 39 works
  3. 3 Volker Albrecht Germany · #2,727,500 worldwide 1.7k citations · 60 works
  4. 4 Susanna Gräfe Germany · #3,779,930 worldwide 1.5k citations · 62 works
All ranked researchers at Biolitec (Germany)

What are the most cited papers from Biolitec (Germany)?

The most cited paper from Biolitec (Germany) is "Temoporfin-loaded invasomes: Development, characterization and in vitro skin penetration studies" (Nina Dragicevic-Curic, Dietrich Scheglmann, Volker Albrecht et al., 2008), with 230 citations. Next come "Efficacy of Photodynamic Therapy on Inflammatory Signs and Two Selected Periodontopathogenic Species in a Beagle Dog Model" (174) and "Killing of Periodontopathogenic Bacteria by Photodynamic Therapy" (171).

Most cited papers
#PaperReleasedCitations
1 Temoporfin-loaded invasomes: Development, characterization and in vitro skin penetration studies Nina Dragicevic-Curic, Dietrich Scheglmann, Volker Albrecht et al. · Journal of Controlled Release 21 Feb 2008 230
2 Efficacy of Photodynamic Therapy on Inflammatory Signs and Two Selected Periodontopathogenic Species in a Beagle Dog Model Bernd W. Sigusch, Anne Pfitzner, Volker Albrecht et al. · Journal of Periodontology Jul 2005 174
3 Killing of Periodontopathogenic Bacteria by Photodynamic Therapy Anne Pfitzner, Bernd W. Sigusch, Volker Albrecht et al. · Journal of Periodontology Oct 2004 171
4 Surface charged temoporfin-loaded flexible vesicles: In vitro skin penetration studies and stability Nina Dragicevic-Curic, Susanna Gräfe, Burkhard Gitter et al. · International Journal of Pharmaceutics 10 Oct 2009 156
5 Development of different temoporfin-loaded invasomes—novel nanocarriers of temoporfin: Characterization, stability and in vitro skin penetration studies Nina Dragicevic-Curic, Dietrich Scheglmann, Volker Albrecht et al. · Colloids and Surfaces B Biointerfaces 28 Dec 2008 142
All 61 most cited papers, with filters and sorting

Which keywords describe research at Biolitec (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, Photodynamic Therapy, Reactive Oxygen Species, Cancer Treatment, Photosensitizers, Singlet Oxygen, Tumor Targeting and Immunotherapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 31 words, with their numbers
  1. Nanoparticles15▲ 32×10 topics
  2. Photodynamic Therapy15▲ 255×5 topics
  3. Reactive Oxygen Species14▲ 76×2 topics
  4. Cancer Treatment8▲ 90×2 topics
  5. Photosensitizers8▲ 963×1 topic
  6. Singlet Oxygen8▲ 963×1 topic
  7. Tumor Targeting6▲ 137×3 topics
  8. Immunotherapy6▲ 25×5 topics
  9. Fluorescence Imaging5▲ 132×1 topic
  10. Photothermal Therapy5▲ 176×1 topic
  11. Self-Assembly2▲ 18×4 topics
  12. Wound Healing2▲ 29×4 topics
  13. Phthalocyanines2▲ 136×1 topic
  14. Porphyrins2▲ 136×1 topic
  15. Inflammation2▲ 2.4×7 topics
  16. Biomedical Applications2▲ 4.6×7 topics
  17. Oxidative Stress2▲ 2.4×4 topics
  18. Microneedles2▲ 181×1 topic
  19. Solid Lipid Nanoparticles2▲ 181×1 topic
  20. Biosensors1▲ 6.8×3 topics
  21. Bioluminescence1▲ 157×1 topic
  22. Imaging1▲ 9.7×2 topics
  23. Low-Level Laser Therapy1▲ 145×1 topic
  24. Photobiomodulation1▲ 145×1 topic
  25. Reporter Genes1▲ 157×1 topic
  26. Antimicrobial Activity1▲ 17×3 topics
  27. Drug Delivery1▲ 6.6×3 topics
  28. Photoaging1▲ 104×1 topic
  29. Skin Cancer1▲ 50×2 topics
  30. UV Radiation1▲ 62×1 topic
  31. Cancer Therapy1▲ 4.4×2 topics

Which research topics does Biolitec (Germany) publish most on?

By volume in 2022-now: Photodynamic Therapy Research Studies, Nanoplatforms for cancer theranostics, Porphyrin and Phthalocyanine Chemistry and Biochemical and biochemical processes.

  1. 1 Photodynamic Therapy Research Studies Pulmonary and Respiratory Medicine 0 works
  2. 2 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  3. 3 Porphyrin and Phthalocyanine Chemistry Materials Chemistry 0 works
  4. 4 Biochemical and biochemical processes Biotechnology 0 works
  5. 5 Skin Protection and Aging Dermatology 0 works
  6. 6 Laser Applications in Dentistry and Medicine Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Advancements in Transdermal Drug Delivery Pharmaceutical Science 0 works
  8. 8 Luminescence and Fluorescent Materials Materials Chemistry 0 works
  9. 9 Lignin and Wood Chemistry Biomedical Engineering 0 works
  10. 10 bioluminescence and chemiluminescence research Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.8%not open69.2%

World: 40% of research is openly available.

with international co-authors50.5%domestic only49.5%

World: 18% is written across borders.

How has Biolitec (Germany)'s research output changed?

Output in 2022-2025 was 47% lower than in 2018-2021.

2005201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Biolitec (Germany) as a percentage of every work published that year, 0.000013% in 2022.

0.00010%0.00020%Biolitec (Germany)0.000011% in 202320102020

Fractional works of Biolitec (Germany) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Jena

All research institutions in Jena

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Biolitec (Germany). Posts are plain text and can be reported.